Browse Categories

Publications by authors named "Baghat Gerges"

  • Page 1 of 1
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.
Kenneth V I Rolston Baghat Gerges Samuel Shelburne Samuel L Aitken Issam Raad

Antimicrob Agents Chemother

April 2020

Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at ≤4 mg/liter. It had potent activity against extended-spectrum β-lactamase-positive , carbapenem-resistant (CRE), and nonfermenting Gram-negative bacilli, including , , and species isolates.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Baghat Gerges"

  • - Baghat Gerges' research primarily investigates the efficacy of the antibiotic Cefiderocol against Gram-negative bacterial infections, particularly in cancer patients.
  • - In his notable 2020 publication, the study found that Cefiderocol demonstrated a remarkable inhibition rate of 97.5% across 478 Gram-negative isolates at concentrations of 4 mg/liter or less.
  • - The research highlighted Cefiderocol's significant effectiveness against challenging pathogens, including extended-spectrum β-lactamase-positive and carbapenem-resistant bacteria, suggesting its potential as a critical treatment option in oncology settings.

Privacy Policy Site Map

© LitMetric 2025. All rights reserved.